Writing the Future of Biologics to Discover and Optimize Antibodies

Dr Aaron Sato presents how Twist Biopharma leverages Twist Bioscience's DNA synthesis technology to rapid end-to-end antibody discovery

View the Webinar

Presented by

Covered in this Webinar

Learn how Twist Biopharma provides end-to-end antibody discovery and optimization solutions such as:

Highly diverse synthetic naïve antibody phage display libraries

Several target class specific antibody phage display libraries against difficult-to-drug targets

High-throughput antibody expression service

Dr. Sato will also present several use cases including the latest on how Twist Biopharma is working to find antibodies against SARS-CoV-2019 S1 spike protein as well as its receptor, ACE2.

Share your details to Watch the Webinar

Genes

Oligo Pools

NGS Target Enrichment Solutions

Variant Libraries

Synthetic Controls

Antibody Discovery

Writing the Future of Biologics to Discover and Optimize Antibodies

Related Resources

Developing Therapeutics Against Virtually Any Target with New Antibody Libraries (Mandarin)

Precision Synthesis of Variant Libraries Enables Comprehensive Interrogation of Single-Site